chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first signs of adverse reaction occurred on the third night after shingles inoculation. Bone ache in ribs and some vertebrae caused insomnia. During the day it's almost gone or was so light that I paid no attention. On the fourth night the ache came back. In the morning (It was the fourth day after the jab) ache became more painful and a small dime-size red rash appeared on my lower right rib. As I was notified about possibility of side effects I didn't heed much. I took a pill of benadryl and a pill of ibuprofen. Next 24 hours I spent air traveling and had no chance to look at my torso skin. But the pain increased significantly - It felt like bone pain in front of my body, right above my belly and under the shoulder blades on the opposite side of my body came with waves. I managed it with ibuprofen (4 pills during 24 hours). So, it was around 120 hours (5 days) after the inoculation when I discovered that the right part of my body was covered by a rash swathed over the lower parts of ribs. 4-5 inches in the front part narrowed under the armpit and widened to the backbone side. Rash included blisters from tiny to one-inch sizes.  I made an appointment with a physician. On the 6th day after vaccination I started treatment 800mg acyclovir every 6 hours and 500 mg Valacyclovir every 7 hours, acyclovir ointment over the rash twice a day. Gabapentin every 5-7 hours was used to suppress pain.  In addition to body skin rash, I noticed that the skull skin became very dry and reddish and two small chicken pox like pimps appeared on the right side of the forehead. Up to now, after 5 days of treatment (12 ones after the jab), redness of affected areas started to wane, just a few blisters did not dry yet, but pain still persists though necessity for gabapentin is only 2 pills a day. I continue the treatment.
Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders; Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders; Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders), PAIN IN EXTREMITY (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders), ARTHRALGIA (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders) and FATIGUE (Very tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced NECK PAIN (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders), PAIN IN EXTREMITY (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders), ARTHRALGIA (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders) and FATIGUE (Very tired). At the time of the report, NECK PAIN (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders), PAIN IN EXTREMITY (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders), ARTHRALGIA (Neck, shoulders, and arms started to hurt/ soreness in the arms neck and shoulders) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
had approx 4 less than 20sec shaking spells (like a chill) in 24hr p/vax given;pt is otherwise doing well;it is hard to know if these were true sz or little temper fits on having sore limbs touched;
Bruise x 2 1/2 weeks from LD to shoulder.  Pts private provider did xrays a couple of weeks post injections, dx frozen shoulder, pt currently receiving PT.
Patient was on schedule for what was listed as a 2nd dose of COVID vaccine. The patient did not have her vaccine card with her but did report she didn't think she needed another dose. The nurse who administered the vaccine did not verify what vaccine in the series the patient was on. Dose administered per how the visit was scheduled.
RE: Pentacel No adverse reaction noted. Realized that the diluent portion of the Pentacel was not mixed with the powder portion after administrating vaccine. Called manufacturer and spoke to pharmacist who advised to give Hib vaccine as a separate vaccination which was done.
Local reaction: slight edema and area of erythema 4-5 cm diam. Urticaria on face, neck and upper shoulder. Rx Benadryl
Vaxelis was given as a 4th dose on 12/2/2022, when indicated for 3 dose series; This non-serious spontaneous safety report, with case ID 02350865/02350805 FR20220700476/FR22-04890, was received by partner, on 10MAR2023 and forwarded on 13MAR2023 from other health professional.  The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Vaxelis was given as a 4th dose on 12/2/2022, when indicated for 3 dose series".  Further information is expected.
Case number PHHY2015US156680, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 594366) website on 02 Nov 2015. This report refers to a female patient of unknown gender. Past medical history was not reported. Concomitant medications included SYSTANE. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) and pneumococcal vaccine (manufacturer unknown and batch number: not reported) on an unknown date. After vaccination, the patient experienced arthritis type pain. The outcome of the event was unknown. The seriousness of the event was reported as non serious and causality of the event was not reported.
Initial report was received from a consumer on 07 September 2012. A male patient (age not reported) received a dose, injection of ADACEL, sanofi pasteur, Ltd., (lot number, route, site and side, dose in series not reported) on an unspecified date. On an unspecified date the patient reported "he might be getting Parkinson's" disease. Past medical history, concomitant medications, complementary investigations and treatments were not reported. No other information was provided. The patient's outcome was not reported. Documents held by sender: None.
Tested for Lyme disease during this and it was positive; Flu-like symptoms; Shortness of breath; Fatigue; This case was reported by a physician via sales rep and described the occurrence of lyme disease in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced lyme disease (serious criteria GSK medically significant), influenza-like symptoms, shortness of breath and fatigue. On an unknown date, the outcome of the lyme disease was unknown and the outcome of the influenza-like symptoms, shortness of breath and fatigue were recovered/resolved.   It was unknown if the reporter considered the lyme disease, influenza-like symptoms, shortness of breath and fatigue to be related to Shingrix.  Additional details were provided as follows: Age at vaccination was not reported. It was reported that after 1st dose, the patient experienced flu-like illness, shortness of breath, fatigue. It took weeks to resolve. The patient was tested for Lyme disease during this and it was positive. This was his first diagnosis of Lyme disease. This occurred about 1 year ago.
No complaint of adverse event. Patient notified COVID-19 vaccine used after being drawn up for more than 12 hours.
Patient stated she felt sudden onset shortness of breath and substernal chest discomfort starting 4/19/2021 just after the noon hour. She presented to the ER at 1:40pm on 4/19/2021. Patient was treated immediatly, including  placing patient on 2L O2, EKG performed, labwork drawn, and 1mg/kg lovenox given SQ. Patient taken for CTA of chest, which showed saddle pulmonary embolism. Patient sent for mechanical thrombectomy, which was performed in the evening of 4/19/2021, and patient admitted to Medical Center for follow up care after procedure.
Pt recv vax on 1/19/99; on 1/20/99 pt exp sore leg; 1/27/99 pt exp fever (102.6), swollen glands; 1/28/99 pt imp
Pt received moderna covid vaccines on 4/24/21, 5/21/21, and 9/8/21.  on 1/31/22 patient admitted to our hospital with fevers, myalgias, and leg pain.  of not patient had covid in early january. pt with fever of 102.7 on 2/1/22 @0950
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Aug2021 as dose 3 (booster), single (Lot number: 301308A), in left arm and on 11Apr2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 62 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results; (01Jun2022) Negative, notes: Tested negative after completing Paxlovid for 3 days; (Jun2022) Positive, notes: rebounded positive with symptoms on Day 11. Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti viral Paxlovid was given from 24May2022 to 29May2022 for treatment of COVID-19
was achy all over the body after the First and 2nd Monovalent Booster; Tired after first and 2nd Monovalent Booster; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (was achy all over the body after the First and 2nd Monovalent Booster) and FATIGUE (Tired after first and 2nd Monovalent Booster) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A and 054A22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, the patient experienced MYALGIA (was achy all over the body after the First and 2nd Monovalent Booster) and FATIGUE (Tired after first and 2nd Monovalent Booster). On 05-Nov-2021, MYALGIA (was achy all over the body after the First and 2nd Monovalent Booster) and FATIGUE (Tired after first and 2nd Monovalent Booster) had resolved.            Concomitant product use was not provided by the reporter.  The patient was feeling achy all over the body and tired for 2 days after second Monovalent Booster from 27-May-2022 to 29-May-2022.             Treatment information was not provided.   This case was linked to MOD-2022-664781, MOD-2022-664782 (Patient Link).
This case was reported by the vaccinating physician and described the occurrence of pallor in a 2 month old male subject who was vaccinated with Pediarix for prophylaxis. There was no relevant medical history. His concurrent medical conditions were not reported. He had not experienced any adverse events following previous vaccinations. On 13 June 2006 at 1:30 pm, the subject received the 1st dose of Pediarix (lot number AC21B067BA, right leg). On the same day, he was also vaccinated with a 1st dose of Prevnar (lot number B17697K) and a 1st dose of ActHib (lot number APUE802AA). On 13 June 2006, approximately four hours after vaccination with Pediarix and following a dose of Tylenol for an unspecified indication, the subject's parents noticed he turned pale and gray and also blue around the eyes. The episode lasted for less than two minutes and then happened again a few minutes later. The second episode also lasted less than two minutes. The subject was taken to the emergency room. An electrocardiogram was performed and was normal. The subject was admitted overnight for observation. He was seen by both a neurologist and a pulmonologist. The subject did not experience anymore episodes and the events resolved on 13 June 2006. He was discharged the next day. The physician considered the events were possibly related to vaccination with Pediarix. Follow up was received on 17 July 2006. According to the reporting physician, the final diagnosis was apneic episode and pallor. The reporting physician considered the events to be life threatening. On 14 June 2006 results from the electroencephalogram were normal. It was reported that the immunization series with Pediarix was discontinued at the parents request.
Reduced mobility, pain, shoulder swelling, believe vaccination was given too high, happened at time vaccination was given.
Pt. having severe reaction on Enbrel injection site after  2nd dose of Moderna vaccine . Redness and itching near the injection site, much worse than an expected injection site reaction, when injecting on both stomach and leg. has advised patient to dc Enbrel and will be starting on Humira.
Then about 6 hours later I started to get burning feet and terrible gas pains; Then about 6 hours later I started to get burning feet and terrible gas pains; That night I woke up in a sweat; Then Nausea came back Tuesday; I could not stop vomiting; I am still having tingling sensations so I have started on electrolytes.; But other then some insomnia last nigh; janssen covid-19 vaccine was administered on the same date; janssen covid-19 vaccine was administered on the same date; This is a spontaneous report from a contactable consumer (patient). A 58-Year-old female patient (no pregnant) received the second dose of bnt162b2 on 15May2021 (at the age of 57-year-old) (lot number: FG3527) via unknown route of administration in arm right at dose 2, single for COVID-19 immunization; janssen covid-19 vaccine on 15May2021 at 02:30 (lot number: 205A21A) via unknown route of administration at dose 1, single in arm right for unknown indication. Medical history was reported as none. Concomitant medications were reported as none. Patient previously took Codeine and experienced Allergies. On 29Oct2021 at 08:00 PM, patient felt fine when she left the store. Then about 6 hours later she started to get burning feet and terrible gas pains. That night she woke up in a sweat, then the next night and the next night also. Then she woke up Monday and felt really good. Then Nausea came back Tuesday and by then she could not stop vomiting and was admitted by ambulance to the hospital. She was still having tingling sensations so had started on electrolytes.  But other then some insomnia last night she was almost back to normal. Treatment included zofran and fluids. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not take any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not have been tested for COVID-19. The outcome of the events was recovering. The events resulted in Emergency room/department or urgent care, hospitalization, Life threatening illness (immediate risk of death from the event). The events did not result in Disability, Congenital anomaly, death and did not prolong Hospitalization.
Pt. came in to see me -  presented with (L) arm redness, tenderness, warmth, palpation - was hard to touch. Instructed ice, ibuprofen, BENADRYL - call with worsening.
Rash on bottom of both arms.  11/27 more rash on front of left lower leg (shin).  Arm rash had several water blisters.   Treated with 1% hydrocortisone cream with little effect. Treated by physician on 11/28 with hydroxyz HCL 25 mg, 3 tabs per day for 7 days. Noticed some clearing by 11/30, 6:00 PM.
Post vax, developed left anterior shoulder pain approximately 2 days later. Describes some pain when rolling down car window and some pain when sleeping on the other shoulder. No erythema or warmth.
Pt. received vaccine 11/25/2013.  Hives noticed on trunk and L upper extremity on monrning of 11/26/2013.  Hives then became more diffuse and began to spread over next 3-4 days over entire body.  Pt took famotidine and Benadryl on 11/26/2013.  Pt say MD on 12/5/2013 after little to no relief.  MD prescribed Medrol dose pack x 2.
Swollen legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swollen legs) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03M20A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included FAMOTIDINE and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen legs). At the time of the report, PERIPHERAL SWELLING (Swollen legs) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient's doctor prescribed a water pill that help a little with her edema.   This case was linked to MOD-2021-032407 (Patient Link).
Pt received imm on 7/18/12 and began with a fever on 7/26/12 and fluid filled blisters on 7/29/11.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. Concurrent condition and medical history were not reported. On an unspecified date, the patients were vaccinated with improperly stored doses of PROQUAD (Lot # K011967, expiration date 21-FEB-2016; Lot# K020756, expiration date 30-APR-2016) (Strength, route and dose were not reported). Concomitant medications were not reported. No adverse reactions were reported. This is one of several reports from the same source. Additional information has been requested.
pt. came to office 2 days past vaccination with large raised area at site of injection (per nurse who observed pt. was advised to go to her MD.  There were no other systemic indications 10/27 spoke with Pt.  who did not see MD after all.  She is ok.  Pt. states had a reaction (similar) to the pneumonia shot last year.  I advised to get flu shots by MD in future.
Two blisters in the back of the throat; Dizziness; Arm hurts; Getting weak; Terrible chills; Terrible body aches; horrible fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL BLISTERING (Two blisters in the back of the throat) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03B21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced OROPHARYNGEAL BLISTERING (Two blisters in the back of the throat) (seriousness criterion medically significant), DIZZINESS (Dizziness), PAIN IN EXTREMITY (Arm hurts), ASTHENIA (Getting weak), CHILLS (Terrible chills), MYALGIA (Terrible body aches) and PYREXIA (horrible fever). At the time of the report, OROPHARYNGEAL BLISTERING (Two blisters in the back of the throat), DIZZINESS (Dizziness), PAIN IN EXTREMITY (Arm hurts), ASTHENIA (Getting weak), CHILLS (Terrible chills), MYALGIA (Terrible body aches) and PYREXIA (horrible fever) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments  Acetaminophen was taken for symptoms.   The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.  Company comments:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-090318 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sore arm was only is; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 20-May-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received Shingles vaccine and experienced sore arm. It was worth the price and side effect was not that bad. Fortunately, the patient's insurance paid part of the cost. Additional Supportive Information: For tolerance of 2nd dose refer case US2022AMR083272.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR083272:Same reporter
Swollen tender, left deltoid, awoke this AM with sxs of sore itching.
Had rash, swelling and itching below injection site on 2/9, followed  with rash  on left midriff and lower right back. This was treated with Triamcinolone 0.5% cream for 4 days, starting 2/15/2021. Rash is gone.
Reported shortness of breath and difficulty swallowing.  O2 given 10L via face mask. Pt declined to go to ED.
Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  Treatment information was not provided. In May 2021, patient received second dose of Moderna COVID 19 Vaccine.   This case was linked to MOD-2021-427018, MOD-2021-427829, MOD-2021-427849 (Patient Link).